A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
|Hero|January 30, 2014
Low-Dose Levonorgestrel IUDs Highly Effective Even After 3 Years of Use
Advertisement
Low-dose levonorgestrel IUDs are safe and effective in preventing pregnancy,and their use could be expanded among women who have not yet had children.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Reactions to FDA's boxed warning removals for menopausal hormone therapy
2
Top headlines in women's health from October 2026
3
Top video interviews from The Menopause Society 2026 Annual Meeting
4
FDA grants accelerated approval to DNA immunotherapy for adult recurrent respiratory papillomatosis
5